SPDR S&P Biotech Stock Quote XBI - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

103.08

Bid

Ask

Volume

7,149,634

101.85 Day's Range 103.52

63.80 52 Week Range 103.52

Market Cap

7.69B

Previous Close

100.81

Open

102.69

Last Trade

100

103.08

Last Trade Time

12:49:13

Financial Volume

$ 735,835,112

VWAP

102.9193

Average Volume (3m)

7,428,488

Shares Outstanding

74,600,000

Dividend Yield

PE Ratio

10.41

Earnings Per Share (EPS)

9.91

Revenue

25.52M

Net Profit

739.09M

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select In... The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI). Show more

Sector

Mgmt Invt Offices, Open-end

Industry

Mgmt Invt Offices, Open-end

Website

www.spdrs.com

Headquarters

Boston, Massachusetts, USA

Founded

SPDR S&P Biotech is listed in the Mgmt Invt Offices, Open-end sector of the American Stock Exchange with ticker XBI. The last closing price for SPDR S&P Biotech was $100.81. Over the last year, SPDR S&P Biotech shares have traded in a share price range of $ 63.80 to $ 103.52.

SPDR S&P Biotech currently has 74,600,000 shares outstanding. The market capitalization of SPDR S&P Biotech is $7.52 billion. SPDR S&P Biotech has a price to earnings ratio (PE ratio) of 10.41.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	4.2	4.24757281553	98.88	103.52	97.96	7881642	100.73977706	SP
4	1	0.979623824451	102.08	103.52	95.43	6601450	99.87012734	SP
12	10.69	11.5705162896	92.39	103.52	90.28	7428488	97.9466672	SP
26	10.44	11.2694300518	92.64	103.52	81.14	8670426	92.99174179	SP
52	27.05	35.5780612916	76.03	103.52	63.8	9975431	87.0059884	SP
156	-27.27	-20.920598389	130.35	134.79	61.78	9941893	86.71416648	SP
260	20.3	24.5228316018	82.78	174.79	61.78	8283125	94.08996959	SP

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GSIWGarden Stage Ltd	$ 5.94 (161.67%)	41.2M
ZEOZeo Energy Corporation	$ 2.4414 (114.16%)	54.06M
TBIOTelesis Bio Inc	$ 2.74 (101.47%)	41.55M
XCURExicure Inc	$ 3.70 (61.57%)	14.34M
EWTXEdgewise Therapeutics Inc	$ 28.0519 (47.10%)	7.93M
HAOHaoxi Health Technology Ltd	$ 0.7497 (-75.01%)	6.19M
XCHXCHG Ltd	$ 8.54 (-53.51%)	897.79k
GDHGGolden Heaven Group Holdings Ltd	$ 2.671 (-35.95%)	379.64k
BLMZBloomZ Inc	$ 0.885 (-35.40%)	509.53k
HOVRNew Horizon Aircraft Ltd	$ 0.48 (-35.22%)	1.92M
NVDANVIDIA Corporation	$ 119.16 (5.11%)	150.86M
SQQQProShares UltraPro Short QQQ	$ 7.67 (-8.69%)	133.7M
MAXNMaxeon Solar Technologies Ltd	$ 0.1065 (17.16%)	73.6M
FRGTFreight Technologies Inc	$ 0.1308 (5.57%)	70.78M
TSLATesla Inc	$ 242.71 (6.83%)	59.91M